Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Benefits drawbacks hydroxychloroquine Plaquenil and chronic fatigue syndrome Physicochemical properties of chloroquine hydrochloride Hydroxychloroquine Plaquenil is a drug that is classified as an anti-malarial drug. Plaquenil is prescribed for the treatment or prevention of malaria. It is also prescribed for the treatment of rheumatoid arthritis, lupus, and the side effects of lupus such as hair loss, joint pain, and more. View detailed reports from patients taking Hydroxychloroquine Sulfate who experienced herpes zoster. Reports are from official medical reports as well as online extractions from user reviews and forum discussions. Summary Herpes zoster is found among people who take Hydroxychloroquine sulfate, especially for people who are female, 60+ old, have been taking the drug for 10+ years, also take medication Enbrel, and have Pain. Plaquenil is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. This medicine is not effective against all strains of malaria. Hydroxychloroquine shingles Hydroxychloroquine Side-effects, uses, time to work, Hydroxychloroquine Sulfate Herpes Zoster Reports. Votamin b deficiency feom plaquenilPlaquenil dark skin Hydroxychloroquine is an antimalarial used to treat rheumatoid arthritis of moderate inflammatory activity. It is effective for mild systemic and discoid lupus erythematosus, particularly involving Shared care guidelines for hydroxychloroquine for rheumatoid.. Will you have Herpes zoster with Hydroxychloroquine sulfate - eHealthMe. Hydroxychloroquine oral and zoster vaccine live pf subq.. Apr 10, 2019 Plaquenil hydroxychloroquine belongs to a group of medicines called quinolines. Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Two doses of Shingrix provides strong protection against shingles and postherpetic neuralgia PHN, the most common complication of shingles. In adults 50 to 69 years old who got two doses, Shingrix was 97% effective in preventing shingles; among adults 70 years and older, Shingrix was 91% effective. Hydroxychloroquine Plaquenil appears to increase the risk of shingles in patients with Rheumatoid arthritis and patients with lupus. Whether it increases the risk in patients with scarring alopecia has not been studied but there is no reason to believe it should not.